Catalyst Biosciences is a drug discovery and development company that is creating novel catalytic biopharmaceutical products based on engineered human proteases. The mission is to establish protease therapeutics as a new therapeutic platform comparable in depth and scope to antibody pharmaceuticals. The Company is developing proteases for the treatment of a broad range of diseases with a strong focus on hemostasis and inflammation.
The Companyâ€™s product discovery platform is based on methods to rapidly create and characterize tailor-made protease drug candidates, called Alteraseâ„¢ therapeutics, that cleave disease-causing proteins or improve the biochemical and pharmacological properties of marketed protease drugs.
Current Team (4)Update
Funding Rounds (7) - $100.9MUpdate
Board Members and Advisors (7)Update
Morgenthaler Ventures is a venture capital and private equity firm that invests in IT and life...
Venture capital subsidiary
Venture capital Firm
Essex Woodlands was founded in 1985 with the establishment of Essex Venture Fund I, LP. Since...
Life Sciences VC
Since 1974, Sofinnova Ventures has partnered with entrepreneurs to secure initial funding, build...
The RCT BioVentures program is the vehicle through which Research Corporation Technologies...
260 Littlefield Avenue
South San Francisco, CA 94080